Skip to main content

Table 4 Infant infection outcomes

From: BabyGel pilot: a pilot cluster randomised trial of the provision of alcohol handgel to postpartum mothers to prevent neonatal and young infant infection-related morbidity in the community

Primary outcome

Control group

Intervention group

Difference (95% CI)

n = 48

n = 51

Screen positive on IMCI form at any point within 90 days after birth

14 (29.2%)

16 (31.4%)

2.2 (− 15.9:20.3)

Sepsis deaths

1 (2.1%)

0

− 2.1 (not calculable)

Clinically diagnosed infection in health centre or hospital

8 (16.7%)

11 (21.6%)

4.9 (− 10.5:20.3)

Mother reported infant infection

19 (39.6%)

26 (51.0%)

11.4 (−8.1:30.9)

Infant received antibiotics

8 (16.7%)

14 (27.5%)

10.8 (− 5.4:26.9)

Infant was hospitalised

3 (6.3%)

6 (11.8%)

5.5 (− 5.7:16.7)

Total with any evidence of non-malaria infection (positive screen, maternal report, or clinical diagnosis)

27 (56.3%)

28 (54.9%)

− 1.3 (− 20.9:18.2)